独立药房声称受到与大型卫生链相连的PBM的压力,由于引导病人和高收费而面临生存能力的威胁。 Independent pharmacies claim being pressure by PBMs linked to large health chains, facing threats to viability due to steering patients and high fees.

独立药店说,它们受到与大型卫生链有关的药店福利管理人员的压力,他们将病人引向附属药店,并收取高额费用。 Independent pharmacies argue they are being pressured by pharmacy benefit managers (PBMs) linked to large health chains, which are steering patients towards affiliated pharmacies and imposing high fees. 这种做法威胁到独立药房的生存能力,因为它们由于报销率低而难以支付费用。 This practice threatens the viability of independent pharmacies, as they struggle to cover costs due to low reimbursement rates. 虽然PBM声称为消费者谈判折扣,但FTC和众议院委员会的报告表明潜在的反竞争行为会伤害消费者和独立药店. While PBMs claim to negotiate discounts for consumers, reports from the FTC and a House committee suggest potential anticompetitive behavior harming both consumers and independent pharmacies.